Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: J Immunol. 2014 Apr 7;192(10):4560–4570. doi: 10.4049/jimmunol.1303461

Figure 4.

Figure 4

Characterization of mouse GFP+MSCs. (A) Isolated and individually expanded GFP+MSCs were analyzed by fluorescence-activated cell sorting (FACS) using antibodies for Sca-1, CD29, CD45, and CD11b. (B) The ability of MSCs to differentiate into fibroblast/myofibroblast was evaluated by the expression of α-SMA (Abcam) with DAPI for nuclei immune-staining after cells were treated with CRE (50μg/ml) for 72 hours.